| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0059 | 0.9 |